|
|
 |
|
Clinical Efficacy and Safety of Mesalamine Suppositories for Pediatric Ulcerative Proctitis
|
|
|
"Clinical efficacy and safety of mesalamine (CanasaTM/SalofalkÒ) suppositories in the treatment of pediatric ulcerative proctitis: A multicenter, open label, parallel group study"
Mesalamine is often used in the treatment of children with ulcerative colitis. However, this agent has not been formally studied in clinical trials in children or teenagers. This study is being sponsored by Axcan Pharmaceuticals and will evaluate the effectiveness and safety of mesalamine suppositories in the treatment of children with inflammation of the lining of the large intestine (colon) in the region of the anus, a clinical condition referred to as ulcerative proctitis.
Contact: Paul A. Rufo, M.D., M.M.Sc. or Anna Zholudev (617-355-3326)
|
|
|
|
|
|
|
